{
  "url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-modification-order-2003/note",
  "json_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-modification-order-2003/note.json",
  "legislation": "ukdsi/2003/0110454901",
  "legislation_title": "The Misuse of Drugs Act 1971 (Modification) Order 2003",
  "legislation_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-modification-order-2003",
  "path": "note",
  "kind": "note",
  "number": null,
  "heading": "Explanatory note",
  "text": "(This note is not part of the Order)\nThis Order adds eight substances to Schedule 2 to the Misuse of Drugs Act 1971 which specifies drugs which are subject to control under the Act. Two of the substances, Dihydroetorphine and Remifentanil are added as Class A drugs; and the remaining six, 4-Androstene-3, 17-dione; 5-Androstene-3, 17-diol; 4-Hydroxy-n-butyric acid; 19-Nor-4-Androstene-3; 17-dione, 19-Nor-5-Androstene-13, 17-diol and Zolpidem are added as Class C drugs.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2003/0110454901/note",
    "retrieved_at": "2026-10-30T15:25:20.802956+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}